QUIESCENT HERPES SIMPLEX KERATITIS REACTIVATION after INTRAVITREAL INJECTION of DEXAMETHASONE IMPLANT

Denis Jusufbegovic, Shlomit Schaal

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose: To report reactivation of herpes simplex virus keratitis after the injection of dexamethasone implant (Ozurdex) and to raise the awareness of this potentially vision threatening side effect. Methods: A 90-year-old man presented with ocular pain and tearing in the left eye 3 weeks after receiving a dexamethasone implant (Ozurdex) for the treatment of macular edema associated with branch retinal vein occlusion. The patient had a history of herpes simplex virus keratitis that was quiescent for more than 30 years. Results: Clinical examination of the left eye showed arborizing epithelial ulcer with terminal bulbs consistent with herpes simplex virus keratitis. Conclusion: Quiescent herpes simplex virus keratitis can be reactivated after dexamethasone implant (Ozurdex). Prophylactic antiviral therapy might be indicated in individuals who have a high risk of recurrent herpetic disease.

Original languageEnglish (US)
Pages (from-to)296-297
Number of pages2
JournalRetinal Cases and Brief Reports
Volume11
Issue number4
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Herpetic Keratitis
Simplexvirus
Dexamethasone
Eye Pain
Retinal Vein Occlusion
Macular Edema
Ulcer
Antiviral Agents
Injections
Therapeutics

Keywords

  • dexamethasone implant
  • herpes simplex keratitis
  • Ozurdex
  • reactivation
  • recurrence

ASJC Scopus subject areas

  • Ophthalmology

Cite this

QUIESCENT HERPES SIMPLEX KERATITIS REACTIVATION after INTRAVITREAL INJECTION of DEXAMETHASONE IMPLANT. / Jusufbegovic, Denis; Schaal, Shlomit.

In: Retinal Cases and Brief Reports, Vol. 11, No. 4, 01.01.2017, p. 296-297.

Research output: Contribution to journalArticle

@article{e509291139d44948831a4492a7739730,
title = "QUIESCENT HERPES SIMPLEX KERATITIS REACTIVATION after INTRAVITREAL INJECTION of DEXAMETHASONE IMPLANT",
abstract = "Purpose: To report reactivation of herpes simplex virus keratitis after the injection of dexamethasone implant (Ozurdex) and to raise the awareness of this potentially vision threatening side effect. Methods: A 90-year-old man presented with ocular pain and tearing in the left eye 3 weeks after receiving a dexamethasone implant (Ozurdex) for the treatment of macular edema associated with branch retinal vein occlusion. The patient had a history of herpes simplex virus keratitis that was quiescent for more than 30 years. Results: Clinical examination of the left eye showed arborizing epithelial ulcer with terminal bulbs consistent with herpes simplex virus keratitis. Conclusion: Quiescent herpes simplex virus keratitis can be reactivated after dexamethasone implant (Ozurdex). Prophylactic antiviral therapy might be indicated in individuals who have a high risk of recurrent herpetic disease.",
keywords = "dexamethasone implant, herpes simplex keratitis, Ozurdex, reactivation, recurrence",
author = "Denis Jusufbegovic and Shlomit Schaal",
year = "2017",
month = "1",
day = "1",
doi = "10.1097/ICB.0000000000000376",
language = "English (US)",
volume = "11",
pages = "296--297",
journal = "Retinal Cases and Brief Reports",
issn = "1935-1089",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - QUIESCENT HERPES SIMPLEX KERATITIS REACTIVATION after INTRAVITREAL INJECTION of DEXAMETHASONE IMPLANT

AU - Jusufbegovic, Denis

AU - Schaal, Shlomit

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Purpose: To report reactivation of herpes simplex virus keratitis after the injection of dexamethasone implant (Ozurdex) and to raise the awareness of this potentially vision threatening side effect. Methods: A 90-year-old man presented with ocular pain and tearing in the left eye 3 weeks after receiving a dexamethasone implant (Ozurdex) for the treatment of macular edema associated with branch retinal vein occlusion. The patient had a history of herpes simplex virus keratitis that was quiescent for more than 30 years. Results: Clinical examination of the left eye showed arborizing epithelial ulcer with terminal bulbs consistent with herpes simplex virus keratitis. Conclusion: Quiescent herpes simplex virus keratitis can be reactivated after dexamethasone implant (Ozurdex). Prophylactic antiviral therapy might be indicated in individuals who have a high risk of recurrent herpetic disease.

AB - Purpose: To report reactivation of herpes simplex virus keratitis after the injection of dexamethasone implant (Ozurdex) and to raise the awareness of this potentially vision threatening side effect. Methods: A 90-year-old man presented with ocular pain and tearing in the left eye 3 weeks after receiving a dexamethasone implant (Ozurdex) for the treatment of macular edema associated with branch retinal vein occlusion. The patient had a history of herpes simplex virus keratitis that was quiescent for more than 30 years. Results: Clinical examination of the left eye showed arborizing epithelial ulcer with terminal bulbs consistent with herpes simplex virus keratitis. Conclusion: Quiescent herpes simplex virus keratitis can be reactivated after dexamethasone implant (Ozurdex). Prophylactic antiviral therapy might be indicated in individuals who have a high risk of recurrent herpetic disease.

KW - dexamethasone implant

KW - herpes simplex keratitis

KW - Ozurdex

KW - reactivation

KW - recurrence

UR - http://www.scopus.com/inward/record.url?scp=85032003868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032003868&partnerID=8YFLogxK

U2 - 10.1097/ICB.0000000000000376

DO - 10.1097/ICB.0000000000000376

M3 - Article

C2 - 27508424

AN - SCOPUS:85032003868

VL - 11

SP - 296

EP - 297

JO - Retinal Cases and Brief Reports

JF - Retinal Cases and Brief Reports

SN - 1935-1089

IS - 4

ER -